Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560091 | 12756009 | 1 | I | 20160910 | 20160916 | 20160916 | EXP | PHHY2016ES125559 | SANDOZ | SAFONT A, DONAZAR M, GASTON B, BARRENETXEA J, URTASUN M, GARCIA S ET AL.. FETAL SUPRAVENTRICULAR TACHYCARDIA IN A TRIPLET PREGNANCY. JOURNAL OF MATERNAL-FETAL + NEONATAL MEDICINE. 2016;29:124-5 | 0.00 | Y | 0.00000 | 20160916 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560091 | 12756009 | 1 | PS | DIGOXIN. | DIGOXIN | 1 | Transplacental | UNK | D | 40481 | |||||||||
| 127560091 | 12756009 | 2 | SS | DIGOXIN. | DIGOXIN | 1 | Transplacental | UNK | D | 40481 | |||||||||
| 127560091 | 12756009 | 3 | SS | FLECAINIDE | FLECAINIDE | 1 | Transplacental | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127560091 | 12756009 | 1 | Foetal exposure during pregnancy |
| 127560091 | 12756009 | 3 | Foetal exposure during pregnancy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127560091 | 12756009 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127560091 | 12756009 | Foetal exposure during pregnancy | |
| 127560091 | 12756009 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |